Aberdeen Group plc Buys 47,996 Shares of Johnson & Johnson $JNJ

robot
Abstract generation in progress

Aberdeen Group plc recently increased its stake in Johnson & Johnson (NYSE:JNJ) by 1.9% in the fourth quarter, purchasing 47,996 additional shares and making J&J its 13th-largest holding. Other institutional investors like Wellington Management, Bank of New York Mellon, and Legal & General also boosted their positions. While J&J benefits from institutional confidence, a new $500M R&D deal, positive trial data, and expected dividend increases, it faces risks from China MedTech weakness, valuation concerns after a significant rally, and recent insider selling.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin